Forskning ved Københavns Universitet - Københavns Universitet

Forside

Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production. / Jensen, Jørgen Dejgaard; Christensen, Tove; Olsen, Jakob Vesterlund; Sandøe, Peter.

I: Value in Health, Bind 23, Nr. 1, 2020, s. 89–95.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, JD, Christensen, T, Olsen, JV & Sandøe, P 2020, 'Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production', Value in Health, bind 23, nr. 1, s. 89–95. https://doi.org/10.1016/j.jval.2019.07.006

APA

Jensen, J. D., Christensen, T., Olsen, J. V., & Sandøe, P. (2020). Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production. Value in Health, 23(1), 89–95. https://doi.org/10.1016/j.jval.2019.07.006

Vancouver

Jensen JD, Christensen T, Olsen JV, Sandøe P. Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production. Value in Health. 2020;23(1):89–95. https://doi.org/10.1016/j.jval.2019.07.006

Author

Jensen, Jørgen Dejgaard ; Christensen, Tove ; Olsen, Jakob Vesterlund ; Sandøe, Peter. / Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production. I: Value in Health. 2020 ; Bind 23, Nr. 1. s. 89–95.

Bibtex

@article{6e6ec3770c6e4071ba35c24373ccedc8,
title = "Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production",
abstract = "Background: Livestock-acquired methicillin-resistant Staphylococcus aureus (LA-MRSA) is a concern in healthcare and a political priority in some countries. Objective: This study investigates the net societal costs of 2 alternative strategies for controlling LA-MRSA in Denmark: (1) eradicating LA-MRSA in all pig housing units, and (2) containing LA-MRSA within the units. Methods: Benefits and costs are considered for affected economic sectors: healthcare, pig production, pig-related industries, and public administration. Results: The cost to society of eradication is estimated at €2.3 to €2.5 billion (present value). Containment will cost €55 to €93 million. For both strategies, the main cost lies in primary pig production—for containment this is mainly due to establishing and operating anterooms and shower rooms, and for eradication it is due to production losses, loss of genetic resources, and costs of cleaning and disinfection. Conclusion: Compared with these costs, health economic benefits are moderate for both strategies. Containment is superior to eradication when measured by a benefit-cost ratio.",
keywords = "containment, costs, eradication, MRSA CC398",
author = "Jensen, {J{\o}rgen Dejgaard} and Tove Christensen and Olsen, {Jakob Vesterlund} and Peter Sand{\o}e",
year = "2020",
doi = "10.1016/j.jval.2019.07.006",
language = "English",
volume = "23",
pages = "89–95",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Costs and benefits of alternative strategies to control the spread of livestock-acquired methicillin-resistant Staphylococcus Aureus from pig production

AU - Jensen, Jørgen Dejgaard

AU - Christensen, Tove

AU - Olsen, Jakob Vesterlund

AU - Sandøe, Peter

PY - 2020

Y1 - 2020

N2 - Background: Livestock-acquired methicillin-resistant Staphylococcus aureus (LA-MRSA) is a concern in healthcare and a political priority in some countries. Objective: This study investigates the net societal costs of 2 alternative strategies for controlling LA-MRSA in Denmark: (1) eradicating LA-MRSA in all pig housing units, and (2) containing LA-MRSA within the units. Methods: Benefits and costs are considered for affected economic sectors: healthcare, pig production, pig-related industries, and public administration. Results: The cost to society of eradication is estimated at €2.3 to €2.5 billion (present value). Containment will cost €55 to €93 million. For both strategies, the main cost lies in primary pig production—for containment this is mainly due to establishing and operating anterooms and shower rooms, and for eradication it is due to production losses, loss of genetic resources, and costs of cleaning and disinfection. Conclusion: Compared with these costs, health economic benefits are moderate for both strategies. Containment is superior to eradication when measured by a benefit-cost ratio.

AB - Background: Livestock-acquired methicillin-resistant Staphylococcus aureus (LA-MRSA) is a concern in healthcare and a political priority in some countries. Objective: This study investigates the net societal costs of 2 alternative strategies for controlling LA-MRSA in Denmark: (1) eradicating LA-MRSA in all pig housing units, and (2) containing LA-MRSA within the units. Methods: Benefits and costs are considered for affected economic sectors: healthcare, pig production, pig-related industries, and public administration. Results: The cost to society of eradication is estimated at €2.3 to €2.5 billion (present value). Containment will cost €55 to €93 million. For both strategies, the main cost lies in primary pig production—for containment this is mainly due to establishing and operating anterooms and shower rooms, and for eradication it is due to production losses, loss of genetic resources, and costs of cleaning and disinfection. Conclusion: Compared with these costs, health economic benefits are moderate for both strategies. Containment is superior to eradication when measured by a benefit-cost ratio.

KW - containment

KW - costs

KW - eradication

KW - MRSA CC398

U2 - 10.1016/j.jval.2019.07.006

DO - 10.1016/j.jval.2019.07.006

M3 - Journal article

C2 - 31952677

AN - SCOPUS:85071947598

VL - 23

SP - 89

EP - 95

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 1

ER -

ID: 228531778